8260 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 

appropriateness, accuracy of 

information, courtesy, efficiency of 

service delivery, and resolution of 

issues with service delivery. Responses 

will be assessed to plan and inform 

efforts to improve or maintain the 

quality of service offered to the public. 

If this information is not collected, vital 

feedback from customers and 

stakeholders on CDC’s services will be 

unavailable. 

CDC will only submit an individual 

collection for approval under this 

Generic clearance mechanism if it meets 

the following conditions: 

• The collection is voluntary; 

• The collection is low-burden for 

respondents (based on considerations of 

total burden hours, total number of 

respondents, or burden-hours per 

respondent) and are low-cost for both 

the respondents and the federal 

government; 

• The collection is non-controversial 

and does not raise issues of concern to 

other federal agencies; 

• The collection is targeted to the 

solicitation of opinions from 

respondents who have experience with 

the program or may have experience 

with the program in the near future; 

• Personally identifiable information 

(PII) is collected only to the extent 

necessary and is not retained; 

• Information gathered is intended to 

be used only internally for general 

service improvement and program 

management purposes and is not 

intended for release outside of the 

agency (if released, the agency must 

indicate the qualitative nature of the 

information); 

• Information gathered will not be 

used for the purpose of substantially 

informing influential policy decisions; 

and 

• Information gathered will yield 

qualitative information (the collection 

will not be designed or expected to 

yield statistically reliable results or used 

as though the results are generalizable to 

the population of study). 

Feedback collected under this CDC 

Generic clearance provides useful 

information, but it does not yield data 

that can be generalized to the overall 

population. This type of Generic 

clearance for qualitative information 

will not be used for quantitative 

information collections that are 

designed to yield reliably actionable 

results, such as monitoring trends over 

time or documenting program 

performance. Such data uses require 

more rigorous designs that address: The 

target population to which 

generalizations will be made, the 

sampling frame, the sample design 

(including stratification and clustering), 

the precision requirements or power 

calculations that justify the proposed 

sample size, the expected response rate, 

methods for assessing potential nonresponse bias, the protocols for data 

collection, and any testing procedures 

that were or will be undertaken prior to 

fielding the study. Depending on the 

degree of influence the results are likely 

to have, such collections may still be 

eligible for submission for other Generic 

mechanisms that are designed to yield 

quantitative results. 

As a general matter, individual 

information collections will not result 

in any new system of records containing 

privacy information and will not ask 

questions of a sensitive nature, such as 

sexual behavior and attitudes, religious 

beliefs, and other matters that are 

commonly considered private. 

Based on the number of burden hours 

used during the previous approval 

period and the number of respondents 

involved in this and other expiring 

collections, CDC requests OMB approval 

for an estimated 22,250 annual burden 

hours. There are no costs to respondents 

other than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average hours 

per response 

Total response 

burden 

(hours) 

Individuals and Households, Businesses and Organizations, State, 

Local or Tribal Government.

In-person surveys, Online surveys, 

Telephone surveys, In-person observation/testing, Interviews.

10,000 1 30/60 5,000 

Focus groups ................................... 1,000 1 2 2,000 

Customer comment cards, Interactive Voice surveys.61,000 1 15/60 15,250 

Total ........................................... ........................................................... ........................ ........................ ........................ 22,250 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–03079 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment to the Advisory Council 

for the Elimination of Tuberculosis 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) is seeking 

nominations for membership on the 

Advisory Council for the Elimination of 

Tuberculosis (ACET). The ACET 

consists of 10 experts including the 

Chair in fields associated with public 

health, epidemiology, immunology, 

infectious disease, pulmonary disease, 

pediatrics, tuberculosis, microbiology, 

and preventive health care delivery. 

ACET provides advice and 

recommendations regarding the 

elimination of tuberculosis (TB) to the 

Secretary, HHS; the Assistant Secretary 

for Health, HHS; and the CDC Director. 

ACET (a) makes recommendations on 

policies, strategies, objectives, and 

priorities; (b) addresses development 

and application of new technologies; (c) 

provides guidance and review of CDC’s 

TB prevention research portfolio and 

program priorities; and (d) reviews the 

extent to which progress has been made 

toward eliminating TB. 

DATES: Nominations for membership on 

the ACET must be received no later than 

May 31, 2022. Packages received after 

this time will not be considered for the 

current membership cycle. 

ADDRESSES: All nominations should be 

mailed to CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, Georgia 

30329–4027; or emailed (recommended) 

to nchhstppolicy@cdc.gov; or faxed to 

(404) 639–8600. 

FOR FURTHER INFORMATION CONTACT: 

Marah Condit, MS, Committee 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8261 

Management Lead, National Center for 

HIV, Viral Hepatitis, STD, and TB 

Prevention, CDC, 1600 Clifton Road NE, 

Mailstop US8–6, Atlanta, Georgia 

30329–4027, Telephone: (404) 639– 

3423; Email: MCondit@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Nominations are being sought for 

persons who have expertise and 

qualifications necessary to contribute to 

the accomplishments of the council’s 

objectives. Nominees will be selected on 

the basis of their expertise in public 

health, epidemiology, immunology, 

infectious diseases, pulmonary disease, 

pediatrics, tuberculosis, microbiology, 

or preventive health care delivery. 

Federal employees will not be 

considered for membership. Members 

may be invited to serve for up to fouryear terms. 

Selection of members is based on 

candidates’ qualifications to contribute 

to the accomplishment of ACET 

objectives. 

The U.S. Department of Health and 

Human Services policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens 

and cannot be full-time employees of 

the U.S. Government. Current 

participation on federal workgroups or 

prior experience serving on a federal 

advisory committee does not disqualify 

a candidate; however, HHS policy is to 

avoid excessive individual service on 

advisory committees and multiple 

committee memberships. Committee 

members are Special Government 

Employees (SGEs), requiring the filing 

of financial disclosure reports at the 

beginning and annually during their 

terms. CDC reviews potential candidates 

for ACET membership each year and 

provides a slate of nominees for 

consideration to the Secretary of HHS 

for final selection. HHS notifies selected 

candidates of their appointment near 

the start of the term in July 2023, or as 

soon as the HHS selection process is 

completed. Note that the need for 

different expertise varies from year to 

year and a candidate who is not selected 

in one year may be reconsidered in a 

subsequent year. SGE nominees must be 

U.S. citizens and cannot be full-time 

employees of the U.S. Government. 

Candidates should submit the following 

items to be considered: 

D Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

and email address). 

D At least one letter of 

recommendation from person(s) not 

employed by the U.S. Department of 

Health and Human Services. Candidates 

may submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (i.e., CDC, 

NIH, FDA, etc.). 

Nominations may be submitted by the 

candidate himself or herself or by a 

person or organization recommending 

the candidate. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03036 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–1132; Docket No. CDC–2022– 

0023] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Performance Progress and 

Monitoring Report (PPMR). The PPMR 

is designed to allow CDC to collect 

information related to CDC Awardee’s 

budgets, strategies and activities, and 

the process and outcome performance 

measures outlined by the cooperative 

agreement programs, in order to 

evaluate partnerships and the work that 

is done on behalf of CDC. 

DATES: CDC must receive written 

comments on or before April 15, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0023 by either of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 


jspears on DSK121TN23PROD with NOTICES1